-+ 0.00%
-+ 0.00%
-+ 0.00%

OVID THERAPEUTICS INC - OV4071 ON TRACK FOR REGULATORY SUBMISSION FOR PHASE 1/1B CLINICAL TRIAL IN Q1 2026

Reuters·12/18/2025 13:06:53

Please log in to view news